🔍

SADHNANIQ - Sadhana Nitro

📊 NSE: SADHNANIQ 🏢 Chemicals 📅 Last Updated: 12/14/2025 12:36

📢 Recent Corporate Announcements

Sadhana Nitrochem to Raise ₹13.9 Cr via Preferential Issue; EGM Scheduled for May 22

🟢 POSITIVE ⭐ 7/10

FUNDRAISE 📅 30 Apr 2026, 05:08 PM

Sadhana Nitrochem Limited has scheduled an Extraordinary General Meeting (EGM) on May 22, 2026, to seek approval for a preferential allotment of 6.75 crore equity shares. The company aims to raise approximately ₹13.905 crore by issuing shares at ₹2.06 each to private investors Niraj Bajaj and Poorvi Milan Chitalia. Other key agenda items include increasing the authorized share capital to ₹305 crore and the continuation of Mr. Asit Javeri as Executive Director beyond the age of 70. This capital infusion and leadership continuity are central to the company's immediate strategic plans.

Preferential allotment of 6,75,00,000 equity shares at ₹2.06 per share to raise ₹13.905 crore.
Lead investor Niraj Bajaj to be allotted 5,25,00,000 shares, representing the bulk of the issue.
Proposal to increase Authorized Share Capital from ₹300 crore to ₹305 crore.
EGM to be held via Video Conferencing on May 22, 2026, with a cut-off date of May 15 for voting eligibility.
Special resolution for the continuation of Mr. Asit Dhankumar Javeri as Executive Director beyond age 70.

💡 Investors should note the equity dilution resulting from the 6.75 crore new shares but view the entry of a strategic investor like Niraj Bajaj as a positive endorsement. Monitor the company's subsequent disclosures regarding the specific utilization of these funds for growth or debt reduction.

Sadhana Nitrochem Reports Compliance with SEBI Demat Regulations for Q4 FY26

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 10 Apr 2026, 03:16 PM

Sadhana Nitrochem Limited has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for the quarter ended March 31, 2026. The company, through its RTA MUFG Intime India, confirmed that 21,284 shares were successfully dematerialized during this period. All security certificates received were mutilated and cancelled within the prescribed 15-day timeline, ensuring the depository names were correctly updated in the register of members. This is a standard administrative filing confirming the company's adherence to regulatory shareholding processes.

Processed dematerialization requests for 21,284 shares during the quarter ended March 31, 2026.
Total share capital of the company stands at 2,964,694,385 shares of Rs. 1 each.
Confirmed 100% compliance with the 15-day processing timeline for security certificates.
Physical mode shares remaining as of March 31, 2026, total 327,257,667.
The Registrar and Share Transfer Agent (RTA) confirmed all certificates were duly mutilated and cancelled.

💡 No action is required from investors as this is a routine regulatory filing confirming administrative compliance. It indicates the company's internal processes for share management are functioning correctly.

Sadhana Nitrochem Constitutes TCWG Committee and Appoints Nodal Officer

🟡 NEUTRAL ⭐ 4/10

REGULATORY 📅 30 Mar 2026, 03:49 PM

Sadhana Nitrochem Limited has constituted a committee of 'Those Charged With Governance' (TCWG) in compliance with the National Financial Reporting Authority (NFRA) circular dated January 7, 2026. The board approved this formation via a circular resolution on March 30, 2026. Mr. Mukul S. Mehra has been appointed as the Chairman and Nodal Officer of this committee. The committee includes four members: Mukul S. Mehra, Abhishek A. Javeri, Nayan M. Patel, and Tej M. Contractor, aimed at strengthening financial oversight.

Formation of TCWG committee as per NFRA circular dated January 7, 2026
Appointment of Mr. Mukul S. Mehra as Chairman and Nodal Officer
Committee consists of 4 members to oversee governance and reporting
Resolution passed by the Board of Directors via circular resolution on March 30, 2026

💡 This is a routine regulatory compliance update aimed at improving corporate governance and financial reporting. No immediate action is required from investors.

Sadhana Nitrochem to Close Trading Window from April 1, 2026 for FY26 Results

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 25 Mar 2026, 03:06 PM

Sadhana Nitrochem Limited has announced the closure of its trading window effective from April 1, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations. This closure is specifically for the quarter and financial year ending March 31, 2026. The restriction applies to all designated persons and their immediate relatives to ensure regulatory compliance ahead of the audited financial results. The trading window will remain closed until 48 hours after the official declaration of the financial results to the stock exchanges.

Trading window closure begins on Wednesday, April 1, 2026.
Restriction pertains to the audited financial results for the quarter and year ending March 31, 2026.
Window will reopen 48 hours after the financial results are declared to BSE and NSE.
NSDL is designated to freeze PANs at the security level for ISIN-INE888C01040.
Compliance is in accordance with SEBI Circular dated July 19, 2023.

💡 This is a routine regulatory announcement with no impact on company fundamentals. Investors should wait for the upcoming audited financial results to assess the company's performance.

Sadhana Nitrochem Receives Trading Approval for 263.52 Crore Rights Issue Shares

🔵 WATCH ⭐ 8/10

FUNDRAISE 📅 16 Mar 2026, 07:47 PM

Sadhana Nitrochem Limited has secured final trading approval from both BSE and NSE for 2,63,52,83,328 equity shares issued via its recent Rights Issue. These shares, with a face value of Re. 1 each, were issued at par and will be admitted for trading effective March 17, 2026. This marks the completion of a massive equity expansion, which will significantly increase the company's total share capital and liquidity in the market.

Trading approval received for 2,63,52,83,328 equity shares of Re. 1/- each.
New shares were issued at par (Re. 1) on a rights basis.
Trading of the new shares is scheduled to commence on March 17, 2026.
Approval letters received from BSE (LOD/RIGHTS/SV/69/2025-2026) and NSE (NSE/LIST/2026/54054).

💡 Investors should be cautious as the massive influx of over 263 crore new shares may lead to significant equity dilution and short-term price volatility. Monitor how the company utilizes the raised capital to drive future earnings growth to offset the dilution.

Sadhana Nitrochem Allots 263.5 Crore Equity Shares via Rights Issue at ₹1 Each

🟡 NEUTRAL ⭐ 8/10

FUNDRAISE 📅 12 Mar 2026, 07:14 PM

Sadhana Nitrochem Limited has successfully completed the allotment of 263,52,83,328 equity shares following its Rights Issue. The shares were issued at a price of ₹1 per equity share, significantly expanding the company's equity base. As a result, the paid-up equity share capital has increased from ₹32.94 crore to ₹296.47 crore. While 5,128 shares are kept in abeyance pending clearances, the new shares will rank pari-passu with existing equity.

Allotment of 263,52,83,328 fully paid-up equity shares at an issue price of ₹1 per share
Paid-up equity share capital increased from ₹32,94,11,057 to ₹2,96,46,94,385
5,128 Rights Equity Shares kept in abeyance pending regulatory or other clearances
New shares rank pari-passu in all respects with existing fully paid-up equity shares

💡 Investors should be aware of the significant equity dilution as the share capital has increased nearly nine-fold. Monitor the company's utilization of these funds and the subsequent impact on Earnings Per Share (EPS).

Sadhana Nitrochem Appoints Sindhu Suneer Kotian as Independent Director for 5-Year Term

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 07 Mar 2026, 07:30 PM

Sadhana Nitrochem Limited has appointed Mrs. Sindhu Suneer Kotian as a Non-Executive Independent Director for a five-year term starting March 07, 2026. Mrs. Kotian is a seasoned legal professional with over 25 years of experience in litigation, arbitration, and corporate advisory at the Bombay High Court. The appointment, which is subject to shareholder approval, is intended to strengthen the board's legal and regulatory oversight. This move follows the recommendation of the company's Nomination and Remuneration Committee.

Appointment of Mrs. Sindhu Suneer Kotian as Non-Executive Independent Director for a 5-year tenure.
The term of appointment is effective from March 07, 2026, through March 06, 2031.
Mrs. Kotian brings over 25 years of legal expertise in corporate advisory and litigation.
The appointee is not related to any existing directors and is not debarred by SEBI.

💡 This is a routine board-level appointment that enhances the company's governance profile with legal expertise. No immediate action is required from investors as this does not impact daily operations or financial performance.

Sadhana Nitrochem Appoints Sindhu Suneer Kotian as Independent Director for 5-Year Term

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 07 Mar 2026, 07:27 PM

Sadhana Nitrochem Limited has approved the appointment of Mrs. Sindhu Suneer Kotian as a Non-Executive Independent Director. The appointment is set for a five-year term effective from March 07, 2026, to March 06, 2031, subject to shareholder approval. Mrs. Kotian is a seasoned legal professional with over 25 years of experience in litigation, arbitration, and corporate advisory at the Bombay High Court. This appointment aims to strengthen the board's legal and governance oversight.

Appointment of Mrs. Sindhu Suneer Kotian as Non-Executive Independent Director for a 5-year term.
Tenure commences on March 07, 2026, and concludes on March 06, 2031.
Appointee brings over 25 years of legal expertise in corporate advisory and litigation.
The appointment is based on the recommendation of the Nomination and Remuneration Committee.
Confirmation is subject to the final approval of the company's shareholders.

💡 This is a routine management update to strengthen board governance. Investors should view this as a neutral development with no immediate impact on stock valuation.

Sadhana Nitrochem Sets February 19, 2026, as Record Date for Rights Issue

🟡 NEUTRAL ⭐ 7/10

FUNDRAISE 📅 17 Feb 2026, 03:25 PM

Sadhana Nitrochem Limited has officially designated February 19, 2026, as the record date for its upcoming Rights Issue. This date is crucial as it determines which shareholders are eligible to receive Rights Entitlements (REs) in their demat accounts. The company is proceeding with this capital raising activity in compliance with SEBI Listing and Disclosure requirements. Investors must hold the shares on or before this date to participate in the offering.

The official record date for the Rights Issue is fixed for February 19, 2026.
The purpose is to identify shareholders eligible for Rights Entitlements under the proposed issue.
The announcement follows compliance with Regulation 42 of SEBI LODR and Regulation 68 of SEBI ICDR.
The ISIN for the Rights Entitlement is identified as INE888C20024.

💡 Existing shareholders should check the rights price and ratio once announced to decide on exercising their rights. Those wishing to participate must ensure they hold the shares by the record date to receive entitlements.

Sadhana Nitrochem Approves ₹263.53 Crore Rights Issue with 8:1 Ratio

🔵 WATCH ⭐ 9/10

FUNDRAISE 📅 13 Feb 2026, 03:02 PM

Sadhana Nitrochem Limited has finalized the terms for a significant rights issue totaling ₹263.53 crore. The company will issue 263.53 crore new equity shares at a price of Re. 1 per share, which is at par with the face value. Existing shareholders are entitled to 8 new shares for every 1 share held as of the record date. The record date for this corporate action is set for February 19, 2026.

Total rights issue size fixed at ₹26,352.92 lakhs (approximately ₹263.53 crore)
Rights entitlement ratio set at 8 fully paid-up equity shares for every 1 share held
Issue price determined at Re. 1 per share, representing zero premium over face value
Record date for eligibility established as February 19, 2026
Total number of fresh rights shares to be issued is 263,52,92,056

💡 Investors should be aware of the massive equity dilution resulting from the 8:1 ratio and decide whether to subscribe to maintain their ownership percentage. Monitor the stock price closely as it will likely adjust significantly on the ex-rights date.

Sadhana Nitrochem Q3 Results: Revenue Drops 81% YoY to ₹5.66 Cr; Posts ₹25.4 Cr Net Loss

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 10 Feb 2026, 06:03 PM

Sadhana Nitrochem reported a dismal set of numbers for Q3 FY26, with revenue from operations crashing 81% YoY to ₹5.66 crore. The company swung to a net loss of ₹25.40 crore from a profit of ₹0.64 crore in the previous year's corresponding quarter. Management highlighted technical constraints, liquidity challenges, and US tariff-related trade uncertainties as the primary drivers for this downturn. For the nine-month period, the company has accumulated a net loss of ₹53.48 crore, significantly impacting its financial health.

Quarterly revenue from operations plummeted to ₹566.26 lakhs from ₹2,975 lakhs YoY.
Net loss for Q3 FY26 widened to ₹2,540 lakhs compared to a profit of ₹64 lakhs in Q3 FY25.
Finance costs rose to ₹688 lakhs from ₹464 lakhs YoY, reflecting increased debt servicing pressure.
Total comprehensive loss for the nine-month period ended Dec 2025 stood at ₹5,361 lakhs.
Management cited US tariff uncertainties and technical production constraints as primary reasons for the decline.

💡 The sharp decline in revenue and mounting losses suggest significant operational and external headwinds. Investors should remain cautious and monitor the promised Q4 recovery closely before making new commitments.

Sadhana Nitrochem Reports Q3 Net Loss of ₹25.4 Cr; Revenue Drops 81% YoY

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 10 Feb 2026, 05:53 PM

Sadhana Nitrochem Limited reported a standalone net loss of ₹25.40 crore for the quarter ended December 31, 2025, a sharp decline from a profit of ₹0.64 crore in the same period last year. Revenue from operations fell significantly by 81% YoY to ₹5.66 crore, although it showed a sequential recovery from the previous quarter's low of ₹0.26 crore. The company cited technical production constraints, liquidity challenges, and global trade uncertainties in US and European markets as primary reasons for the poor performance. Management expects an operational recovery in Q4 FY26 as these issues have reportedly been addressed.

Standalone revenue from operations plummeted 81% YoY to ₹5.66 crore from ₹29.75 crore.
Reported a net loss of ₹25.40 crore in Q3 FY26 against a profit of ₹0.64 crore in Q3 FY25.
9-month standalone net loss reached ₹53.48 crore compared to a profit of ₹1.23 crore in the prior year period.
Finance costs increased to ₹6.88 crore from ₹4.64 crore YoY, reflecting higher interest burden.
Management attributed losses to technical constraints and US tariff-related uncertainties affecting export schedules.

💡 Investors should exercise caution as the company has transitioned to significant losses and a severely reduced revenue base. The stock remains a 'Watch' to see if the management's guidance of a Q4 recovery and resolution of technical/liquidity issues actually translates into improved financials.

Sadhana Nitrochem Re-constitutes Board Committees; Appoints Tej Mayur Contractor as Member

🟡 NEUTRAL ⭐ 3/10

MANAGEMENT 📅 05 Feb 2026, 05:16 PM

Sadhana Nitrochem Limited has announced the re-constitution of four key board committees following a circular resolution passed on February 05, 2026. Mr. Tej Mayur Contractor (DIN: 00454197) has been appointed as a member of the Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, and CSR Committee. This administrative update is part of the company's routine corporate governance and compliance with SEBI Listing Regulations. The changes are effective immediately and do not impact the company's operational or financial status.

Mr. Tej Mayur Contractor (DIN: 00454197) appointed as a member of the Audit Committee.
Re-constitution of the Nomination and Remuneration Committee to include Mr. Contractor.
Stakeholders Relationship and CSR Committees also re-constituted with the same appointment.
All resolutions were approved via circular resolution on February 05, 2026.

💡 This is a routine governance update regarding committee composition. No immediate action is required from investors as it does not affect the company's business fundamentals.

Sadhana Nitrochem Shareholders Approve Appointment of Tej Mayur Contractor as Independent Director

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 16 Jan 2026, 04:46 PM

Sadhana Nitrochem Limited has announced the successful passage of a special resolution via postal ballot for the appointment of Mr. Tej Mayur Contractor as a Non-Executive Independent Director. The resolution received overwhelming support, with 99.91% of the total 101.4 million votes cast in favor. While promoter participation was high at 99.59%, public institutional participation was nil, and public non-institutional participation stood at 1.35%. This appointment is part of the company's efforts to maintain its board governance and regulatory compliance.

Special resolution passed to appoint Mr. Tej Mayur Contractor as Non-Executive Independent Director.
Total of 101,425,451 votes were polled, representing 30.79% of the total 329,411,057 shares.
The resolution received 99.91% approval (101,330,857 votes) from the participating shareholders.
Promoter group showed strong support with 98,313,829 votes cast, all 100% in favor of the appointment.
Public non-institutional shareholders cast 3,111,622 votes, with 96.96% in favor and 3.04% against.

💡 This is a routine corporate governance update and requires no immediate action from investors. Shareholders should continue to monitor the company's operational performance and any strategic shifts resulting from board changes.

Sadhana Nitrochem Reports 99.35% Share Capital in Demat Form for Q3 FY26

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 12 Jan 2026, 02:09 PM

Sadhana Nitrochem has submitted its quarterly compliance certificate regarding the dematerialization of shares for the period ending December 31, 2025. As of the quarter-end, approximately 327.26 million shares, representing 99.35% of the total share capital, are held in electronic form. During the quarter, 18,514 shares were successfully processed for dematerialization within the mandated timelines. Only a small fraction of 2.15 million shares remains in physical form.

Total share capital stands at 329,411,057 shares of Rs. 1 face value as of December 31, 2025
18,514 shares were successfully dematerialized during the October-December 2025 quarter
99.35% of the company's total equity is now held in dematerialized format (327,257,667 shares)
The company confirmed compliance with SEBI timelines for processing demat requests within 15 days

💡 This is a routine regulatory filing confirming the electronic status of shares. No specific action is required from investors as it does not impact the company's fundamentals.

View All SADHNANIQ Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Total revenue from operations declined 29.38% YoY to INR 135.99 Cr in FY25, compared to INR 192.86 Cr in FY24. The decline was driven by lower sales across all product segments and the management's decision to halt Para Amino Phenol (PAP) production due to competitive import pricing.

Profitability Margins

Net profit margin remained stable at 3.91% in FY25 compared to 3.92% in FY24. Profit After Tax (PAT) for FY25 was INR 5.22 Cr, down 29.5% from INR 7.41 Cr in FY24.

EBITDA Margin

EBITDA margin improved to 29.37% in FY25 from 23.45% in FY24. This 592 bps improvement was driven by higher profitability on specific products like ODB2, despite the overall revenue decline.

Capital Expenditure

Fixed assets increased by INR 41.90 Cr (13.5% increase) to INR 352.10 Cr in FY25, up from INR 310.20 Cr in FY24, primarily reflecting the capacity enhancement of the PAP plant.

Credit Rating & Borrowing

The company's credit rating is IVR D (Default). Borrowing costs are high, with finance costs reaching INR 17.65 Cr in FY25 (13% of revenue). The company has ongoing delays in servicing term loans and overutilization of cash credit limits.

⚙️ Operational Drivers

Capacity Expansion

Para Amino Phenol (PAP) capacity was enhanced to 6,000 TPA, achieved in September 2024. However, the plant remained non-operational in H2FY25 due to market conditions.

Raw Material Costs

Cost of materials consumed was INR 64.02 Cr in FY25, representing 47.08% of total revenue, down from INR 71.88 Cr in FY24.

📈 Strategic Growth

Growth Strategy

Growth is targeted through vertical integration, plant automation, and upskilling the workforce in AI/IoT applications. The company aims to establish end-to-end visibility of production and dispatch to enhance competitiveness.

Products & Services

Para Amino Phenol (PAP), ODB2, and Metanilic Acid.

New Products/Services

ODB2 is highlighted as a high-margin product contributing to EBITDA growth.

🌍 External Factors

Industry Trends

The industry is shifting toward digital infrastructure for supply chain visibility and predictive maintenance. Current trends include significant pressure from low-cost imports and a focus on vertically integrated manufacturing to mitigate cost risks.

Competitive Landscape

Intense competition from Chinese manufacturers who are selling products at historically low prices.

Competitive Moat

The company's moat is built on its vertically integrated manufacturing approach and 50-year history of serving multinational conglomerates, which provides a sustainable advantage in quality control and process optimization.

Macro Economic Sensitivity

Sensitive to global economic slowdowns and domestic demand fluctuations in the chemical industry.

Geopolitical Risks

High sensitivity to trade dynamics with China, specifically dumping practices that impact domestic margins.

⚖️ Regulatory & Governance

Industry Regulations

Operations are subject to Maharashtra Pollution Control Board (MPCB) consents and safety legislations (ISO 9001, OHSAS 18001).

Environmental Compliance

The company maintains ISO 14001:2004 certification and focuses on socially responsible waste and effluent management.

Taxation Policy Impact

The effective tax rate for FY25 was approximately 42.8%, with tax expenses of INR 3.91 Cr on a PBT of INR 9.13 Cr.

Legal Contingencies

A fire incident in the chemical storage area at the Roha plant in September 2024 resulted in the deaths of contract workers, leading to regulatory inspections and local agitation.

⚠️ Risk Analysis

Key Uncertainties

Uncertainty regarding the resumption of PAP production and the company's ability to regularize debt servicing for more than 90 days to improve its credit rating.